Glyburide

CAS 10238-21-8 10 current records 7 historicalSmall Molecule

Who holds supplier records for Glyburide? 10 organisations hold a current record for Glyburide: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (2), China (1), Czechia (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Glyburide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/glyburide

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Glyburide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Glyburide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Glyburide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
USV PRIVATE LIMITED MumbaiIN
CEP 2000-090 - Rev 06
Glibenclamide, Non-micronised, micronised
Mar 2026—
SRI KRISHNA PHARMACEUTICALS LIMITED HyderabadIN
CEP 2000-289 - Rev 10
Glibenclamide
Jun 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2004-192 - Rev 06
Glibenclamide
Dec 2023—
ZENTIVA K.S. Praha 10CZ
R1-CEP 2003-223 - Rev 07
Glibenclamide, Milled
Feb 2022—
ELIXIR PHARMA AhmedabadIN
R1-CEP 2012-042 - Rev 00
Glibenclamide
Sept 2019—
LUSOCHIMICA S.P.A. PisaIT
R1-CEP 2005-195 - Rev 00
Glibenclamide
May 2014—
Orgapharm PithiviersFR
R1-CEP 2006-134 - Rev 02
Glibenclamide, Micronised
Jul 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Glyburide are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • India · Inactive DMF 19236 · filed Mar 2006
  • CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
    Inactive DMF 18266 · filed Apr 2005
  • AVENTIS PHARMA DEUTSCHLAND GMBH
    Inactive DMF 12165, 12136 · filed Oct 1996
  • HOECHST CELANESE CORP
    Inactive DMF 11179 · filed Nov 1994
  • SELOC FRANCE
    Inactive DMF 11055 · filed Sept 1994
  • CADILA LABORATORIES PVT LTD
    Inactive DMF 7989 · filed Mar 1989
  • FARMOS GROUP LTD MEDIPOLAR
    Inactive DMF 7638 · filed Aug 1988

Overview

Glyburide is an oral diabetes medication that helps control blood sugar levels by stimulating the release of the body's natural insulin. It is used to treat type 2 diabetes and is often prescribed in conjunction with diet and exercise.

Chemical identity

IUPAC name
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
Canonical SMILES
COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
InChIKey
ZNNLBTZKUZBEKO-UHFFFAOYSA-N
Synonyms
cirara, diabeta, glibenclamide, glibenclamidum, glucovance component glyburide, glybenclamide, glynase, hb 419, hb-419, micronase, nsc-759618, u-26,45

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Sulfonylurea
Chemical structure
Sulfonylurea Compounds

Therapeutic areas

EndocrinologyDiabetes Management

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Glyburide?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Glyburide: APITORIA PHARMA PRIVATE LTD (India), LUSOCHIMICA SPA (Italy), SRI KRISHNA PHARMACEUTICALS LTD (India), USV PRIVATE LTD (India), Cadila Pharmaceuticals Limited (India), CAMBREX PROFARMACO MILANO SRL (Italy), TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD (China) and ZENTIVA KS (Czechia), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Glyburide Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 17152), LUSOCHIMICA SPA (DMF 9430), SRI KRISHNA PHARMACEUTICALS LTD (DMF 27045), USV PRIVATE LTD (DMF 15821, 14339), Cadila Pharmaceuticals Limited (DMF 17093), CAMBREX PROFARMACO MILANO SRL (DMF 7675), TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD (DMF 29921) and ZENTIVA KS (DMF 18018). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Glyburide records mean?

7 organisations have only inactive Type II DMFs for Glyburide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Glyburide have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Glyburide on the EDQM register, including USV PRIVATE LIMITED Mumbai (IN), SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), ZENTIVA K.S. Praha 10 (CZ), ELIXIR PHARMA Ahmedabad (IN) and LUSOCHIMICA S.P.A. Pisa (IT) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Glyburide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Glyburide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.